Silje Watterdal Syversen

10PUBLICATIONS
27CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityInnate immunityToxicology (incl. clinical toxicology)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 19, 2026
Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial.

Teresa Holly, Marthe Kirkesaether Brun, Kristin Kaasen Jørgensen

|Nov 13, 2024
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.

Johanna Elin Gehin, Rolf Anton Klaasen, Eirik Klami Kristianslund

|Apr 10, 2024
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.

Hilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton

|Nov 20, 2023
Therapeutic Drug Monitoring: A Tool to Optimize Treatment of Inflammatory Joint Diseases.

Silje W Syversen, Johanna E Gehin, Guro L Goll

|Feb 27, 2023
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.

Marthe Kirkesaether Brun, Kristin Hammersbøen Bjørlykke, Marte K Viken

|Nov 03, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy.

Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter

Pageof 2

Frequent Collaborators

7 joint publications

Guro Løvik Goll

5 joint publications

Johanna Elin Gehin

5 joint publications

Tore K Kvien

4 joint publications

Sella Aarrestad Provan